These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 32493084)
1. Frequency-specific efficacy of intratympanic steroid on idiopathic sudden sensorineural hearing loss. Suzuki H; Ohbuchi T; Do BH; Nguyen TN; Wakasugi T; Ohkubo JI; Kitamura T Acta Otolaryngol; 2020 Sep; 140(9):756-760. PubMed ID: 32493084 [No Abstract] [Full Text] [Related]
2. Efficacy of Intratympanic Steroid on Idiopathic Sudden Sensorineural Hearing Loss: An Analysis of Cases With Negative Prognostic Factors. Suzuki H; Kawaguchi R; Wakasugi T; Do BH; Kitamura T; Ohbuchi T Am J Audiol; 2019 Jun; 28(2):308-314. PubMed ID: 31046392 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Suzuki H; Hashida K; Nguyen KH; Hohchi N; Katoh A; Koizumi H; Ohbuchi T Laryngoscope; 2012 May; 122(5):1154-7. PubMed ID: 22447636 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two different steroid treatments with hyperbaric oxygen for idiopathic sudden sensorineural hearing loss. Sevil E; Bercin S; Muderris T; Gul F; Kiris M Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2419-26. PubMed ID: 26538427 [TBL] [Abstract][Full Text] [Related]
5. Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss. Yang CH; Wu RW; Hwang CF Otol Neurotol; 2013 Oct; 34(8):1411-6. PubMed ID: 24005170 [TBL] [Abstract][Full Text] [Related]
6. Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss. Suzuki H; Koizumi H; Ohkubo J; Hohchi N; Ikezaki S; Kitamura T Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3101-7. PubMed ID: 26879994 [TBL] [Abstract][Full Text] [Related]
7. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Fujimura T; Suzuki H; Shiomori T; Udaka T; Mori T Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):861-6. PubMed ID: 17340130 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Two Different Treatment Protocols Using Systemic and Intratympanic Steroids with and without Hyperbaric Oxygen Therapy in Patients with Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Controlled Trial. Cho I; Lee HM; Choi SW; Kong SK; Lee IW; Goh EK; Oh SJ Audiol Neurootol; 2018; 23(4):199-207. PubMed ID: 30380530 [TBL] [Abstract][Full Text] [Related]
9. The Efficacy of Concurrent or Sequential Intravenous and Intratympanic Steroid for Idiopathic Sudden Sensorineural Hearing Loss. Chu CH; Chiou SR; Wang MC; Shiao AS; Tu TY; Lin LY; Huang CY; Liao WH Audiol Neurootol; 2018; 23(5):277-284. PubMed ID: 30537751 [TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen therapy with short duration intratympanic steroid therapy for sudden hearing loss. Filipo R; Attanasio G; Viccaro M; Russo FY; Mancini P; Rocco M; Pietropaoli P; Covelli E Acta Otolaryngol; 2012 May; 132(5):475-81. PubMed ID: 22292673 [TBL] [Abstract][Full Text] [Related]
11. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Cvorovic L; Jovanovic MB; Milutinovic Z; Arsovic N; Djeric D Otol Neurotol; 2013 Aug; 34(6):1021-6. PubMed ID: 23820795 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of the additional effect of hyperbaric oxygen therapy in combination of systemic steroid and prostaglandin E Hara S; Kusunoki T; Honma H; Kidokoro Y; Ikeda K Am J Otolaryngol; 2020; 41(2):102363. PubMed ID: 31818456 [TBL] [Abstract][Full Text] [Related]
13. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Gouveris H; Schuler-Schmidt W; Mewes T; Mann W Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933 [TBL] [Abstract][Full Text] [Related]
14. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Alimoglu Y; Inci E; Edizer DT; Ozdilek A; Aslan M Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1735-41. PubMed ID: 21431435 [TBL] [Abstract][Full Text] [Related]
16. Comparison of intratympanic dexamethasone therapy and hyperbaric oxygen therapy for the salvage treatment of refractory high-frequency sudden sensorineural hearing loss. Sun H; Qiu X; Hu J; Ma Z Am J Otolaryngol; 2018; 39(5):531-535. PubMed ID: 29891394 [TBL] [Abstract][Full Text] [Related]
17. Addition of intratympanic steroid or hyperbaric oxygen treatment to systemic steroid treatment in sudden idiopathic sensorineural hearing loss treatment, and long-term results of salvage treatment. Keseroğlu K; Toptaş G; Uluat A; Bayir Ö; Çadalli Tatar E; Saylam G; Korkmaz MH; Özdek A Turk J Med Sci; 2020 Feb; 50(1):177-183. PubMed ID: 31865663 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss. Suzuki H; Wakasugi T; Kitamura T; Koizumi H; Do BH; Ohbuchi T Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):235-240. PubMed ID: 29411622 [TBL] [Abstract][Full Text] [Related]
19. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss. Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460 [TBL] [Abstract][Full Text] [Related]
20. Hyperbaric oxygen (HBO) therapy as an effective approach to the treatment of patients with severe idiopathic sudden sensorineural hearing loss. Choi Y; Choi HL; Jeong AY; Kang WS; Park HJ; Chung JW; Ahn JH Acta Otolaryngol; 2020 May; 140(5):383-386. PubMed ID: 32049552 [No Abstract] [Full Text] [Related] [Next] [New Search]